Non-ketotic hyperglycemic hemichorea
Non-ketotic hyperglycemic hemichorea (NHH), also known as diabetic striatopathy or chorea, hyperglycemia, basal ganglia (C-H-BG) syndrome, is a rare neurological complication of non-ketotic hyperglycemia, along with non-ketotic hyperosmolar coma and non-ketotic hyperglycemic seizures. It is a cause of hemichorea-hemiballismus syndrome.
Epidemiology
Non-ketotic hyperglycemic hemichorea is most frequently reported in elderly patients, typically Asian, who have type 2 diabetes mellitus, although this may represent publication bias . The majority of cases published involved female patients .
Clinical presentation
Chorea and ballismus develops rapidly and can be either unilateral or bilateral and is seen during episodes of non-ketotic hyperglycemia. Symptoms usually resolve upon normalization of glucose levels.
Pathology
The exact underlying pathophysiology of changes seen on imaging of patients with non-ketotic hyperglycemic hemichorea is not fully understood .
Some hypothesized mechanisms include :
- hyperviscosity secondary to hyperglycemia, leading to regional blood-brain barrier disruption and metabolic damage
- the augmented sensitivity of dopaminergic receptors in a postmenopausal period (possibly explaining the female predominance in reported case series)
- decreased gamma-aminobutyric acid (GABA) availability in the striatum secondary to the non-ketotic state
Radiographic features
CT
CT of the brain initially is normal, but later it can demonstrate subtle hyperdensity in the striatal region (caudate nuclei and putamen) . Findings tend to be contralateral to the body side affected by hemiballistic, hemichoreic movements.
MRI
MRI of the brain is the modality of choice for assessing possible non-ketotic hyperglycemic hemichorea and typically demonstrates signal changes particularly in the putamen and/or caudate . If the changes are unilateral, then they are contralateral to the symptomatic side .
- T1: hyperintense
- T2/FLAIR: variable but generally hypointense
- DWI: high diffusion signal
Overall, the T1 hyperintensity is the most consistent finding of the disease. Other associated findings do not present to the same frequency and tend to vary .
Imaging findings gradually resolve after hyperglycemia correction. However, they tend to return to baseline more slowly than the clinical findings .
Treatment and prognosis
Symptoms and imaging findings usually resolve upon normalization of glucose levels , and there is no need for specific management.
Differential diagnosis
The main MRI differential is that of other causes of increased T1 signal in the basal ganglia (including Wilson disease) and of a striatocapsular infarct .
Some causes of striatal hyperdensity on CT include :